Research Article: Implications of anemia in patients undergoing PCI with Impella-support: insights from the PROTECT III study
Abstract:
Background: Anemia is prevalent among patients with cardiovascular disease and is associated with adverse outcomes. However, data regarding the impact of anemia in high-risk percutaneous coronary intervention (HRPCI) are limited.
Introduction:
Objectives: This study aimed to evaluate the impact of anemia in patients undergoing Impella-supported HRPCI in the PROTECT III study.
Read more